ALDH1A1 and ovarian carcinoma: As already proven in our previous research and by others, the ALDH1A1-positive populations of ovarian cancer cells were more resistant to chemotherapeutic drugs used in the standard treatment of ovarian cancer patients [6,21,23,24,52,53].